BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer
Abstract PLK1 is currently at the forefront of mitotic research and has emerged as a potential target for small cell lung cancer (SCLC) therapy. However, the factors influencing the efficacy of PLK1 inhibitors remain unclear. Herein, BRCA1 was identified as a key factor affecting the response of SCL...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2024-07-01
|
| Col·lecció: | Cell Death and Disease |
| Accés en línia: | https://doi.org/10.1038/s41419-024-06950-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|